Literature DB >> 16266927

Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.

Thomas Prebet1, Isabelle Tigaud, Sandrine Hayette, Gilles Clapisson, Irène Philip, Mauricette Michallet, Franck E Nicolini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16266927

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  1 in total

Review 1.  Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.

Authors:  Jeffrey A Zonder; Charles A Schiffer
Journal:  Curr Hematol Malig Rep       Date:  2006-09       Impact factor: 3.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.